Collectively, these investigations indicate that SOX5 may regulate voltage-gated L-type Ca2+ channels, and that genetically defective SOX5 may contribute to AF through altering atrial action potential and WNT signaling transduction, as well as atrioventricular conduction. This evidence concerns the gene SOX5 and atrial fibrillation.